Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
NCT00376064
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Acromegaly
Interventions
DRUG:
Octreotide acetate and cabergoline/Octrotide and Somavert
Sponsor
Novartis Pharmaceuticals